scispace - formally typeset
Search or ask a question
Institution

Stratagene

About: Stratagene is a based out in . It is known for research contribution in the topics: Nucleic acid & Gene. The organization has 161 authors who have published 232 publications receiving 17223 citations.


Papers
More filters
Patent
12 Feb 1993
TL;DR: An assay for monitoring and assessing the mutagenic potential of agents which involves creating transgenic non-human animals carrying a test DNA sequence or sequences that can be quickly recovered and examined for mutations following exposure to one or more suspected mutagic agents is described in this paper.
Abstract: An assay for monitoring and assessing the mutagenic potential of agents which involves creating transgenic non-human animals carrying a test DNA sequence or sequences that can be quickly recovered and examined for mutations following exposure to one or more suspected mutagenic agents.

107 citations

Journal ArticleDOI
TL;DR: The in vivo random mutagenesis strategy described in this article, using anE.
Abstract: Random mutagenesis of a cloned gene remains a central method to understand many aspects of the gene products' function and structure. Having the ability to introduce a limited number of changes within a gene in a controlled fashion allows one to evaluate single changes and study the effect these variants have on the gene of interest. The in vivo random mutagenesis strategy described in this article, using anE. coli host, is a convenient method to introduce a limited number of mutations in a controlled manner.

106 citations

Patent
24 Apr 1991
TL;DR: In this article, methods of producing biological agents which express a desired identifiable phenotype are provided. But these methods include bringing together populations of diverse replicas of nucleotide sequences, each comprising one member of each population, expressing the combined nucleotide sequence to give a phenotype and identifying those biological agents expressing the desired phenotype.
Abstract: Methods of producing biological agents which express a desired identifiable phenotype are provided. These methods include bringing together populations of diverse replicas of nucleotide sequences to give a plurality of combined nucleotide sequences, each comprising one member of each population, expressing the combined nucleotide sequences to give a phenotype and identifying those biological agents expressing the desired phenotype.

99 citations

Journal Article
R L Mullinax1, E A Gross, B N Hay, Amberg, M M Kubitz, Sorge Ja 
TL;DR: A fusion-PCR method is used to link the coding regions for heavy and light chain sequences in a single DNA molecule prior to vector ligation, which greatly simplifies the construction of antibody expression clones.
Abstract: A new method is presented for creating antibody expression libraries in Escherichia coli. Rather than perform two cloning steps to express the heavy and light chains of the antigen binding domain, we have used a fusion-PCR method to link the coding regions for heavy and light chain sequences in a single DNA molecule prior to vector ligation. This greatly simplifies the construction of antibody expression clones.

97 citations

Journal ArticleDOI
G S Provost1, J M Short
TL;DR: Transgenic B6C3F1 mice carrying a lacI target gene were exposed to acute and multiple doses of ethylnitrosourea, and germ cells from the seminiferous tubules were assayed for mutation 3 and 90 days after treatment.
Abstract: Transgenic B6C3F1 mice carrying a lacI target gene were exposed to acute and multiple doses of ethylnitrosourea (ENU), and germ cells from the seminiferous tubules were assayed for mutation 3 and 90 days after treatment. Relative to untreated controls, the mutation frequency increased 3.2- and 19.9-fold at 3 and 90 days after treatment, respectively. Mutant lacI genes recovered from untreated and treated groups were sequenced, and the spectra of mutations were determined. Eighty-five percent (11/13) of the spontaneous mutations resulted in G.C-->A.T transitions, all of which occurred at CpG dinucleotides. Fifteen of 22 sites (68%) found mutated 3 days after ENU treatment occurred at G.C base pairs, although some of these are expected to be spontaneous mutations. Ninety days after treatment, 13 of 19 sites (68%) found mutated occurred at A.T base pairs. The mutation spectra seen are consistent with proposed mechanisms of ENU mutagenesis and correlate with the in vivo spectra seen in ENU studies by using transmissibility assays and the hprt gene. These findings represent significant progress toward defining the in vivo spectra of ENU mutagenesis in mammalian germ cells.

97 citations


Authors

Showing all 161 results

NameH-indexPapersCitations
Ronald W. Davis155644151276
Michael Wigler11329863159
Michael McClelland7937227627
Jay M. Short416613812
Joseph A. Sorge29853981
Michael P. Weiner285114127
Quinn Lu21431955
John Welsh20278075
Joseph A. Sorge15362593
Bahram Arezi1218561
Eric J. Mathur12591023
Natalia Novoradovskaya10242527
Holly H. Hogrefe1015525
Jeffrey C. Braman10161084
Patricia L. Kretz8111155
Network Information
Related Institutions (5)
German Cancer Research Center
26.3K papers, 1.4M citations

84% related

National Institutes of Health
297.8K papers, 21.3M citations

83% related

Genentech
17.1K papers, 1.4M citations

83% related

Laboratory of Molecular Biology
24.2K papers, 2.1M citations

83% related

Scripps Research Institute
32.8K papers, 2.9M citations

83% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20081
20078
200620
200510
200415
200318